Skip to main content
Log in

Criteria for interpretation of agar diffusion susceptibility tests of norfloxacin performed by the ICS method

  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Using regression analysis to correlate MIC values and inhibition zone diameters, an attempt was made to establish criteria for interpreting the results of the agar diffusion test with norfloxacin discs (10 mcg). The test was performed on DST agar in accordance with ICS recommendations. The correlation was moderate (r=−0.8547); the regression equation was x=−0.30y + 15.80, where x was log2 MIC + 9 and y the inhibition zone diameter. The position of the MIC breakpoints of norfloxacin and the distribution of the MIC values of the bacterial population did not permit precise inhibition zone breakpoints to be established. To allow a safety margin it is recommended that for the meantime norfloxacin inhibition zones be interpreted as sensitive from 15 mm onwards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Turck, M.: Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 1966, 45: 493–496.

    PubMed  Google Scholar 

  2. Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica 1971, Supplement 217: 1–90.

    Google Scholar 

  3. Shungu, D. L., Weinberg, E., Gadebusch, H. H.: Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715). Antimicrobial Agents and Chemotherapy 1983, 23: 256–260.

    PubMed  Google Scholar 

  4. Woods, S. J., Shadomy, S.: Disk diffusion susceptibility tests with norfloxacin (MK-0366, AM-715): confirmation of proposed interpretive criteria. European Journal of Clinical Microbiology 1983, 2: 242–244.

    PubMed  Google Scholar 

  5. Boppana, V. K., Swanson, B. N.: Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 1982, 21: 808–810.

    PubMed  Google Scholar 

  6. NCCLS Proposed Standard: PSM-7: Standard methods for dilution antimicrobial susceptibility tests for bacteria which grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, PA, 1980, p. 1–31.

    Google Scholar 

  7. DIN 58940, Teil 4, Beiblatt 2: Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika. Bewertungsstufen der minimalen Hemmkonzentration. Liste der durchschnittlichen Tagesdosierungen. Beuth-Verlag, Berlin, 1982.

  8. Metzler, C. M., DeHaan, R. M.: Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. Journal of Infectious Diseases 1974, 130: 588–594.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grimm, H. Criteria for interpretation of agar diffusion susceptibility tests of norfloxacin performed by the ICS method. Eur. J. Clin. Microbiol. 2, 245–248 (1983). https://doi.org/10.1007/BF02029526

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02029526

Keywords

Navigation